Oct 15, 2025 07:19AM ANI Pharmaceuticals (ANIP) PT Raised to $103 at Leerink Partners

Sep 8, 2025 07:23AM ANI Pharmaceuticals (ANIP) PT Raised to $114 at Guggenheim

Aug 11, 2025 09:42AM ANI Pharmaceuticals (ANIP) PT Raised to $77 at Truist Securities

Aug 11, 2025 06:39AM ANI Pharmaceuticals (ANIP) PT Raised to $93 at H.C. Wainwright

Aug 8, 2025 02:01PM ANI Pharmaceuticals (ANIP) PT Raised to $93 at H.C. Wainwright

Jul 29, 2025 04:09PM CG Oncology wins court case, avoids 5% royalty to ANI Pharmaceuticals

Jul 24, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)

Jul 23, 2025 06:51AM ANI Pharmaceuticals reports mixed results from ILUVIEN diabetic eye study

Jul 10, 2025 06:13AM H.C. Wainwright Starts ANI Pharmaceuticals (ANIP) at Buy

May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing

May 9, 2025 06:53AM ANI Pharma (ANIP) Tops Q1 EPS by 36c ; Offers Guidance

Apr 21, 2025 10:41AM ANI Pharmaceuticals (ANIP) PT Raised to $65 at Truist on 'Improved Outlook'

Mar 26, 2025 06:19AM Citi Upgrades 3SBio (1530:HK) (TRSBF) to Buy

Mar 19, 2025 06:50AM ANI Pharma (ANIP) Launches Nitazoxanide Tablets

Mar 18, 2025 06:50AM ANI Pharma (ANIP) Announces Buyout of Royalty Obligation for ILUVIEN and YUTIQ

Mar 14, 2025 06:52AM ANI Pharma (ANIP) Announces FDA Approval for Expansion of ILUVIEN Label

Mar 14, 2025 01:49AM Jefferies Starts ANI Pharmaceuticals (ANIP) at Buy

Mar 12, 2025 03:41AM JPMorgan Starts ANI Pharmaceuticals (ANIP) at Overweight

Mar 3, 2025 04:30PM ANI Pharma (ANIP) Announces FDA Approval of New Purified Cortrophin Gel Prefilled Syringe

Mar 3, 2025 06:31AM Truist Securities Reiterates Hold Rating on ANI Pharmaceuticals (ANIP)

Feb 28, 2025 03:27PM ANI Pharmaceuticals (ANIP) PT Raised to $82 at Leerink Partners

Feb 28, 2025 06:52AM ANI Pharma (ANIP) Tops Q4 EPS by 18c ; Offers Guidance

Jan 13, 2025 06:52AM ANI Pharma (ANIP) Reports Prelim Q4, 2025 Outlook

Jan 2, 2025 06:50AM ANI Pharma (ANIP) Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

Dec 11, 2024 06:20AM Leerink Partners Starts ANI Pharmaceuticals (ANIP) at Outperform

Nov 11, 2024 08:34AM H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)

Nov 8, 2024 06:52AM ANI Pharma (ANIP) Tops Q3 EPS by 26c ; Offers Guidance

Oct 25, 2024 06:51AM ANI Pharma (ANIP) Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

Oct 11, 2024 03:13AM Piper Sandler Starts ANI Pharmaceuticals (ANIP) at Overweight

Sep 26, 2024 06:50AM ANI Pharma (ANIP) Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

Sep 17, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)

Sep 16, 2024 06:51AM ANI Pharma (ANIP) Closes Acquisition of Alimera Sciences (ALIM)

Sep 13, 2024 06:51AM ANI Pharma (ANIP) Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

Sep 11, 2024 06:50AM ANI Pharma (ANIP) and Alimera Sciences (ALIM) Schedule Merger Closing for September 16th

Sep 11, 2024 06:03AM Truist Securities Downgrades ANI Pharmaceuticals (ANIP) to Hold

Sep 10, 2024 02:10PM ANI Pharma (ANIP) Provides Update on Closing of Acquisition of Alimera Sciences (ALIM)

Sep 10, 2024 09:03AM Alimera Sciences (ALIM) Takes Legal Action Against ANI Pharmaceuticals (ANIP) to Enforce Merger Agreement

Aug 7, 2024 07:01AM ANI Pharma (ANIP) Announces Proposed Convertible Senior Notes Offering

Jul 15, 2024 07:00AM ANI Pharma (ANIP) Announces the FDA Approval and Launch of L-Glutamine Oral Powder

Jul 2, 2024 07:00AM ANI Pharma (ANIP) Announces FDA Approval and Launch of Naproxen Delayed-Release Tablets

Jun 26, 2024 06:37AM ANI Pharmaceuticals (ANIP) PT Raised to $94 at H.C. Wainwright

Jun 24, 2024 06:51AM ANI Pharma (ANIP) Acquires Alimera Sciences (ALIM) for $5.50/sh Cash plus $0.50 CVR